Testing antibody therapy for HIV in children
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests whether a combination of special antibodies (bNAbs) can help control HIV without daily medication. It involves several steps and is for children who are already doing well on ART.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 24 weeks old and 12 years old at the start.
- They need to have been on HIV medication (ART) for at least 24 weeks before the study.
- Their viral load (amount of HIV in blood) must be very low (less than 40 copies/mL) for at least 24 weeks.
- They must have no active infections or other serious health problems.
- A parent or guardian must give permission, and if your child is 7-17, they also need to agree to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
This trial tests whether a combination of powerful antibodies (bNAbs) can help control HIV after stopping standard HIV treatment. Participants will pause their daily HIV medications while receiving these antibodies, and doctors will closely monitor their immune system and virus levels. It's for people who are already well-controlled on HIV treatment and have participated in a specific earlier study.
This study checks how safe and well two HIV medicines work in children ages 6 to under 12. It also measures drug levels in the body to guide dosing and watch for side effects.
This study tests a combination of an HIV vaccine and an antibody infusion to see if your immune system can control HIV without daily pills. You would temporarily stop your HIV medication under close monitoring and restart if needed.
This trial tests a combination of an HIV vaccine and a new antibody treatment (GS-2872) to see if it can help control HIV without daily pills. It is for people with well-controlled HIV who are looking for ways to reduce their dependence on antiretroviral therapy.
This study looks at why some HIV-positive children who started treatment early may have a negative HIV antibody test. It uses stored blood samples from children who were in the Pediacam III study to better understand the immune response.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.